GLOBALHealthPR explained

A market-leading global network to suit you.

GLOBALHealthPR is the world’s largest network of independent specialist health and medical communications agencies. Aurora is the UK partner and, together with 17 owner-managed agencies in more than 40 countries, we provide global coverage, allowing us to draw on international best practice and in-depth local knowledge.

Strong and flexible

The members of GLOBALHealthPR are collaborators, not competitors. We’re not pretending to be a global agency – we’re much stronger and more flexible than that!

Through GLOBALHealthPR we implement national, regional and global campaigns that are culturally relevant and deliver for brands across multiple markets.
Each partner agency has completed a rigorous screening process, and demonstrated that their core values and principles complement those of the network. Passion, enthusiasm and commitment to delivering great work are the elements that unite and drive all the partner agencies in the network – as well as a desire for kinship and collaboration across the network.
Together we are greater than the sum of our parts and we’re dedicated to giving our clients access to our collective expertise.

Click here for a copy of The Global Guide to Pharma Marketing Codes. This guide provides information on specific codes and regulations surrounding the promotion of medicines in 16 countries.

Visit the GLOBALHealthPR website or get in touch with Rachel Terry to learn more about how our global network can ensure your brand’s success across multiple markets.

Reimbursography explained

As part of GLOBALHealthPR, we want to share the extensive expertise that our network has. The GLOBALHealthPR strategic communications programme provides country-specific insights on access and how this influences the value context for reimbursement success. We call this ‘Reimbursography’.

Collectively, we believe there is a huge opportunity to redefine market access communications, building the story early in the drug development process and sustaining it throughout the clinical development of a medicine. Across the countries that GLOBALHealthPR represents, we have seen restrictions attached to reimbursement agreements and reluctance of companies to even launch a product in some markets.

Reimbursography reflects the collective capabilities of GLOBALHealthPR to both substantiate and communicate the value of an innovative treatment for funding, access, coverage and reimbursement in markets around the world.

Visit the GLOBALHealthPR website or get in touch to find out more about Reimbursography and discover the key insights four countries of the UK and markets around the world.